Orion Biologics

South Korea’s Samsung Biologics Co.’s new biopharmaceuticals plant launched operations on Tuesday, a move expected to widen the gap betw...

The Life Science Fund, jointly launched by Samsung Biologics and Samsung C&T Corp., announced Wednesday it invested $15 million in US biotech fi...

Samsung Biologics Co., the world’s largest contract drugmaker, plans to double its manufacturing capacity by building four additional plants w...

Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...

South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...

South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...

South Korea's Lotte Group has agreed to buy Bristol Myers Squibb's (BMS) biologics plant in Syracuse in the state of New York for $160 million, the ...

South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO) and a biotech division under the Samsung Group, is set ...

South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...

South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...

The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...

South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...

The IPO of SD Biosensor Inc., which has sold the most COVID-19 test kits in the world -- selling more than 700 million kits from February 2020 to Ma...

Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...

Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...

South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...

South Korea-based confectionery Orion Corp. has set up a plant in India, the second-most populous country in the world, to respond quickly to local ...

Samsung Biologics Co. delivered forecast-beating earnings this week, with its sales topping 1 trillion won ($905 million) for the first time in its ...

SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of capacity, posted an operating profit of 200.2 b...

Samsung Biologics Co. Ltd., the world’s largest contract manufacturing organization (CMO) in terms of capacity, will invest 1.74 trillion won ($...